Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

NCT02464878 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02464878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02464878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2017
Completion date
December 31, 2022
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant, type 1 diabetes